Medications are designed to treat diseased tissues while sparing healthy ones, often by attaching the drug to something that helps guide it directly to its target. But drugs also need time to work, ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Pharmaceutical Technology on MSN
Regulatory round-up: A month of key FDA approvals for cancer drugs
Four cancer drugs have got the FDA nod in May thus far, with approvals spanning haematological and solid tumour indications.
With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Subscribe to read this story ...
Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s, potentially slowing or even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results